125 related articles for article (PubMed ID: 36342136)
1. Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation.
Lickiss B; Gossmann M; Linder P; Thomas U; Dragicevic E; Lemme M; George M; Fertig N; Stölzle-Feix S
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342136
[TBL] [Abstract][Full Text] [Related]
2. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
Yang X; Papoian T
J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
[TBL] [Abstract][Full Text] [Related]
3. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
4. Integration of mechanical conditioning into a high throughput contractility assay for cardiac safety assessment.
Goßmann M; Linder P; Thomas U; Juhasz K; Lemme M; George M; Fertig N; Dragicevic E; Stoelzle-Feix S
J Pharmacol Toxicol Methods; 2020 Sep; 105():106892. PubMed ID: 32629160
[TBL] [Abstract][Full Text] [Related]
5. Safety pharmacology studies using EFP and impedance.
Obergrussberger A; Juhasz K; Thomas U; Stölzle-Feix S; Becker N; Dörr L; Beckler M; Bot C; George M; Fertig N
J Pharmacol Toxicol Methods; 2016; 81():223-32. PubMed ID: 27084108
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the functional maturity of hiPSC-derived cardiomyocytes to assess inotropic compounds.
Zhang X; Aggarwal P; Broeckel U; Abassi YA
J Pharmacol Toxicol Methods; 2023; 123():107282. PubMed ID: 37419294
[TBL] [Abstract][Full Text] [Related]
7. Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance.
Satsuka A; Hayashi S; Yanagida S; Ono A; Kanda Y
J Pharmacol Toxicol Methods; 2022; 118():107227. PubMed ID: 36243255
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes.
Feaster TK; Casciola M; Narkar A; Blinova K
J Vis Exp; 2022 Dec; (190):. PubMed ID: 36591970
[TBL] [Abstract][Full Text] [Related]
9. Inotropic assessment in engineered 3D cardiac tissues using human induced pluripotent stem cell-derived cardiomyocytes in the Biowire
Qu Y; Feric N; Pallotta I; Singh R; Sobbi R; Vargas HM
J Pharmacol Toxicol Methods; 2020 Sep; 105():106886. PubMed ID: 32629159
[TBL] [Abstract][Full Text] [Related]
10. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
[TBL] [Abstract][Full Text] [Related]
11. Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development.
Lickiss B; Hunker J; Bhagwan J; Linder P; Thomas U; Lotay H; Broadbent S; Dragicevic E; Stoelzle-Feix S; Turner J; Gossmann M
J Pharmacol Toxicol Methods; 2024 Jun; 128():107529. PubMed ID: 38857637
[TBL] [Abstract][Full Text] [Related]
12. New easy-to-use hybrid system for extracellular potential and impedance recordings.
Doerr L; Thomas U; Guinot DR; Bot CT; Stoelzle-Feix S; Beckler M; George M; Fertig N
J Lab Autom; 2015 Apr; 20(2):175-88. PubMed ID: 25532527
[TBL] [Abstract][Full Text] [Related]
13. Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiology.
de Lange WJ; Farrell ET; Kreitzer CR; Jacobs DR; Lang D; Glukhov AV; Ralphe JC
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1670-H1686. PubMed ID: 33606581
[TBL] [Abstract][Full Text] [Related]
14. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
[TBL] [Abstract][Full Text] [Related]
15. A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids.
Burnham MP; Harvey R; Sargeant R; Fertig N; Haddrick M
SLAS Discov; 2021 Mar; 26(3):352-363. PubMed ID: 33283596
[TBL] [Abstract][Full Text] [Related]
16. Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts.
Rodriguez ML; Graham BT; Pabon LM; Han SJ; Murry CE; Sniadecki NJ
J Biomech Eng; 2014 May; 136(5):051005. PubMed ID: 24615475
[TBL] [Abstract][Full Text] [Related]
17. The effects of xeno-free cryopreservation on the contractile properties of human iPSC derived cardiomyocytes.
Chirikian O; Feinstein SD; Faynus MA; Kim AA; Lane KV; Torres GV; Pham JV; Singh Z; Nguyen A; Thomas D; Clegg DO; Wu JC; Pruitt BL
J Mol Cell Cardiol; 2022 Jul; 168():107-114. PubMed ID: 35461823
[TBL] [Abstract][Full Text] [Related]
18. An impedance-based cellular assay using human iPSC-derived cardiomyocytes to quantify modulators of cardiac contractility.
Scott CW; Zhang X; Abi-Gerges N; Lamore SD; Abassi YA; Peters MF
Toxicol Sci; 2014 Dec; 142(2):331-8. PubMed ID: 25237062
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes.
Watanabe H; Honda Y; Deguchi J; Yamada T; Bando K
J Toxicol Sci; 2017; 42(4):519-527. PubMed ID: 28717111
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparations.
Rhoden A; Schulze T; Pietsch N; Christ T; Hansen A; Eschenhagen T
Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H373-H385. PubMed ID: 35030072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
